Gene Therapy for Cervical Cancer
A.B. Lucas S.S.
Cervical cancer is the second most common cancer in women. Gene therapy to modify the abnormal proliferation of cancer cells is a potential treatment. DP1 is a major player in cell cycle progression. Cervical cancer cells die when infected with a recombinant adenovirus that encodes a mutant DP1 form which interferes with normal DP1. Thus, dnDP1 is a potential treatment for cervical carcinoma.
|Bronze Medal – Health Sciences
Sponsor: Canadian Institutes of Health Research
|The University of Western Ontario Scholarship
Bronze Medallist – $1000 Entrance Scholarship
Sponsor: University of Western Ontario
My name is Angelica Marie D’Souza and I am 14 years old. I started Grade 9 in September of 2006 at A.B. Lucas Secondary School in London, Ontario. I am on my school’s girls’ rugby team and on the swim team. Outside of school, I dance and take Jazz and Ballet lessons. I volunteer at Humber River Regional Hospital in Toronto. I am also working to earn a Bronze Award of the Duke of Edinburgh Award. I like to scuba dive and collect coins from all over the world. I enjoy reading, especially fantasy, vampire stories, and historical fiction novels. I speak four languages: English, Spanish, Italian, and French. My favourite school subjects are History, French and Math. My post secondary plans vary from month to month, but currently I would like to study History and Modern Languages or Medicine.